EmpNia has achieved a significant milestone with FDA clearance for its eMotus™ respiratory motion management system, designed to enhance precision and efficiency in image-guided radiation therapy (IGRT). Addressing one of radiation oncology’s most persistent challenges—accurately tracking respiratory motion—eMotus offers a novel solution using a disposable sensor pad paired with intuitive software. Unlike existing systems that are often costly, complex, and incompatible with various equipment setups, eMotus installs in hours, requires no capital-intensive infrastructure, and works seamlessly with all imaging and therapy modalities, making it accessible to a wider range of care settings.

The innovation lies in eMotus’ simplicity and universality. Its single-use disposable design eliminates cumbersome hardware and significantly reduces setup time, allowing clinicians to quickly implement respiratory motion tracking across all patient types. This not only improves workflow efficiency but also enhances treatment accuracy by providing reliable, real-time data. By eliminating compatibility issues and avoiding long installation periods, eMotus enables oncology teams to focus more on patient care and less on equipment management—directly addressing key pain points in radiation therapy delivery.

With its FDA clearance, eMotus is poised to become a transformative tool in the field of radiation oncology. It democratizes access to advanced motion management by offering a cost-effective, easy-to-use alternative to traditional systems. This clearance not only validates the technology's safety and effectiveness but also reinforces EmpNia's mission to make precision radiation therapy more practical and widely available. As the system rolls out across hospitals and cancer centers in the U.S., it represents a major step forward in improving outcomes for patients undergoing radiation treatment.

MedTech Spectrum's Summary

FDA-Cleared Innovation: eMotus™ offers a simple, disposable sensor pad system for respiratory motion tracking, now FDA-cleared for use in image-guided radiation therapy.

Universal Compatibility & Efficiency: The system installs quickly, integrates with existing imaging and therapy equipment, and enhances clinical workflow without costly infrastructure.

Broader Access to Precision Care: By reducing complexity and improving usability, eMotus enables more cancer centers to deliver precise, high-quality radiation therapy across all patient types.